Among Medtronic’s other businesses, cardiovascular revenue increased 6.6% to $3.34 billion, neuroscience revenue rose 2.9% to $2.62 billion and medical surgical revenue edged up 0.6% to $2.21 ...

Medtronic, which employs about 10,000 people in Minnesota, reported an adjusted net profit of $1.62 billion on $8.4 billion in sales for its second quarter, which ended Oct. 25.

Medtronic reported a fourth quarter global revenue of nearly $9 billion on Wednesday, totaling more than $33.5 billion globally for fiscal year 2025.

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 ...

Last week, Medtronic announced the intent to separate its diabetes business into a new standalone company. The new company, which remains unnamed, is expected to launch within 18 months.

When Geoff Martha, chairman and CEO of Medtronic, took over the medical device maker’s Restorative Therapies Group in 2015, the company faced a tough decision.

Medtronic said about 80% of the $2.75 billion it collected from diabetes sales during its 2025 fiscal calendar came from recurring sources—such as disposable equipment for its continuous glucose ...